Answers are grounded in this paper and cite their sources.
Perspective highlights patient-reported outcomes in early-phase oncology dosage optimization, suggesting integration with clinical pharmacology improves therapeutic selection.
The authors declared no competing interests for this work. As Deputy Editor-in-Chief of Clinical Pharmacology & Therapeutics, Karthik Venkatakrishnan was not involved in the review or decision process for this paper.
No takes yet. Share an insight, caveat, or question.
Mukker et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: